Fortrea (FTRE) Revenue & Revenue Breakdown
Fortrea Revenue Highlights
Latest Revenue (Y)
$2.72B
Latest Revenue (Q)
$636.50M
Main Segment (Y)
Clinical Services Segment
Main Geography (Y)
North America
Fortrea Revenue by Period
Fortrea Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2025-12-31 | $2.72B | 1.00% |
| 2024-12-31 | $2.70B | -5.14% |
| 2023-12-31 | $2.84B | 0.19% |
| 2022-12-31 | $2.84B | -7.21% |
| 2021-12-31 | $3.06B | 18.49% |
| 2020-12-31 | $2.58B | - |
Fortrea generated $2.72B in revenue during NA 2025, up 1.00% compared to the previous quarter, and up 105.55% compared to the same period a year ago.
Fortrea Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2026-03-31 | $636.50M | -3.63% |
| 2025-12-31 | $660.50M | -5.82% |
| 2025-09-30 | $701.30M | -1.27% |
| 2025-06-30 | $710.30M | 9.06% |
| 2025-03-31 | $651.30M | -6.56% |
| 2024-12-31 | $697.00M | 3.27% |
| 2024-09-30 | $674.90M | 1.89% |
| 2024-06-30 | $662.40M | 0.05% |
| 2024-03-31 | $662.10M | -14.61% |
| 2023-12-31 | $775.40M | 8.63% |
| 2023-09-30 | $713.80M | -1.56% |
| 2023-06-30 | $725.10M | 4.50% |
| 2023-03-31 | $693.90M | 38.06% |
| 2022-12-31 | $502.60M | -34.07% |
| 2022-09-30 | $762.30M | -3.88% |
| 2022-06-30 | $793.10M | 1.81% |
| 2022-03-31 | $779.00M | - |
Fortrea generated $636.50M in revenue during Q1 2026, up -3.63% compared to the previous quarter, and up 91.32% compared to the same period a year ago.
Fortrea Revenue Breakdown
Fortrea Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 25 | Dec 24 |
|---|---|---|
| Clinical Services Segment | $2.72B | $2.70B |
Fortrea's latest annual revenue breakdown by segment (product or service), as of Dec 25: Clinical Services Segment (100.00%).
Quarterly Revenue by Product
| Product/Service | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 23 | Sep 23 | Jun 23 |
|---|---|---|---|---|---|---|---|---|
| Clinical Services Segment | $636.50M | $660.50M | $701.30M | $710.30M | $651.30M | $1.40B | $711.70M | $726.10M |
Fortrea's latest quarterly revenue breakdown by segment (product or service), as of Mar 26: Clinical Services Segment (100.00%).
Fortrea Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 25 | Dec 24 |
|---|---|---|
| Europe | $851.70M | $800.00M |
| Other Geographical Areas | $582.10M | $626.90M |
| North America | $1.29B | $1.27B |
Fortrea's latest annual revenue breakdown by geography, as of Dec 25: North America (47.35%), Europe (31.27%), and Other Geographical Areas (21.37%).
Quarterly Revenue by Country
| Country | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Mar 24 |
|---|---|---|---|---|---|---|---|---|
| Europe | $213.90M | $219.50M | $213.20M | $218.70M | $200.30M | $399.90M | $191.80M | $208.30M |
| Other Geographical Areas | $125.80M | $137.90M | $155.40M | $147.30M | $141.50M | $315.60M | $163.40M | $147.90M |
| North America | $296.80M | $303.10M | $332.70M | $344.30M | $309.50M | $643.90M | $319.70M | $305.90M |
Fortrea's latest quarterly revenue breakdown by geography, as of Mar 26: North America (46.63%), Europe (33.61%), and Other Geographical Areas (19.76%).
Fortrea Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| FTRE | Fortrea | $2.72B | $636.50M |
| ANAB | AnaptysBio | $234.60M | $25.56M |
| PHAT | Phathom Pharmaceuticals | $175.11M | $58.30M |
| VIR | Vir Bio | $68.56M | $-29.00K |
| KURA | Kura Oncology | $67.48M | $18.27M |
| MRVI | Maravai LifeSciences | $49.87M | $65.84M |
| EYPT | EyePoint Pharmaceuticals | $31.37M | $696.00K |
| PROK | ProKidney | $893.00K | $226.00K |
| BBOT | BridgeBio Oncology Therapeutics | - | - |
| XNCR | Xencor | - | $43.61M |
| AVBP | ArriVent BioPharma | - | - |